- Chemical proteomics platform Jnana Therapeutics completes US$50 million in Series B financing
- 2021-08-23
- Recently, in Boston, Jnana Therapeutics, a biotechnology company, used its next-ge...
- More >
- Bayer interception and Vividion IPO
- 2021-08-05
- news Today, the German pharmaceutical company Bayer announced th...
- More >
- Develop KRAS dual inhibitor! Seven months after "handing in" with AbbVie, this upstart company raised US$88.5 million in Series B financing
- 2021-08-02
- On July 19, Frontier Medicines, a cutting-edge small molecule drug research and de...
- More >
- Vividion Therapeutics: Small molecule drug company targeting transcription factors applies for IPO
- 2021-06-28
- Vividion Therapeutics submitted a preliminary prospectus of US$100 million, and th...
- More >
- BridGene Biosciences announced that it has reached a cooperation with Takeda Pharmaceuticals to jointly develop small-molecule drugs for "un-druggable" targets
- 2021-03-31
- Sunnyvale, California, USA March 30, 2021 - BridGene Biosciences, Inc. a...
- More >
